physician photo

Aaron Abarbanell, MD, MS

Assistant Professor of Surgery

Medical School

Medical Degree, University of Michigan, Ann Arbor, 2006

Post Doctoral Education

General Surgery Residency, Indiana University, 2013

Cardiac Surgery Research Fellowship, Indiana University, 2010 

Thoracic Surgery Residency, Emory University, Atlanta, 2016

Congenital Heart Surgery Fellowship, Children’s Hospital of Los Angeles/University of Southern California, Los Angeles, 2017

Board Certifications

Certified - Surgery
Certified - Thoracic Surgery

Clinical Interests

All facets of congenital heart surgery

Research Interests

  • Clinical outcomes and registry database research in infants and young children undergoing cardiac surgery
  • Partnership building and delivery of cardiothoracic surgical services to low- and middle-income countries

Hospital Affiliations

St. Louis Children's Hospital

Patients Seen At

St Louis Children’s Hospital
One Children’s Place
St. Louis, MO  63110
314-454-6165

Selected Publications

Herrmann JL, Fiege JW, Abarbanell AM, Weil BR, Wang Y, Poynter JA, Manukyan MC, Brewster BD, Meldrum DR. TGF-alpha equalizes age disparities in stem cell-mediated cardioprotection. J Surg Res. 2012 Dec;176(2):386-394.

Luo, Y, Wang Y, Poynter JA, Manukyan MC, Herrman JL, Abarbanell AM, Weil BR, Meldrum DR. Pretreating mesenchymal stem cells with interleukin-1beta and transforming growth factor-beta synergistically increases vascular endothelial growth factor production and improves mesenchymal stem cell-mediated myocardial protection after acute ischemia. Surgery. 2012 Mar;151(3):353-63.

Herrmann JL, Abarbanell AM, Wang Y, Weil BR, Poynter JA, Manukyan MC, Meldrum DR. Transforming Growth Factor-alpha Enhances Stem Cell-Mediated Postischemic Myocardial Protection. Ann Thorac Surg. 2011 Nov;92(5):1719-25.

Weil BR, Herrmann JL, Abarbanell AM, Manukyan MC, Poynter JA, Meldrum DR. Intravenous infusion of mesenchymal stem cells is associated with improved myocardial function during endotoxemia. Shock. 2011 Sep;36(3):235-41.

Poynter JA, Herrmann JL, Manukyan MC, Wang Y, Abarbanell AM, Weil BR, Brewster BD, Meldrum DR. Intracoronary mesenchymal stem cells promote postischemic myocardial functional recovery, decrease inflammation, and reduce apoptosis via a signal transducer and activator of transcription 3 mechanism. J Am Coll Surg. 2011 Aug;213(2):253-60.

Manukyan MC, Keck AC, Poynter JA, Wang Y, Weil BR, Abarbanell AM, Herrmann JL, Crowe BJ, Alvernaz C, Meldrum DR. Transforming growth factor-alpha does not protect myocardium during acute ischemia/reperfusion. Surgery. 2011 Aug;150(2):339-46

Poynter JA, Manukyan MC, Wang Y, Brewster BD, Herrmann JL, Weil BR, Abarbanell AM, Meldrum DR. Systemic pretreatment with dimethyloxalylglycine increases myocardial HIF-1 alpha and VEGF production and improves functional recovery after acute ischemia/reperfusion. Surgery. 2011 Aug;150(2):278-83.

Crowe B, Poynter JA, Manukyan MC, Wang Y, Brewster BD, Herrmann JL, Abarbanell AM, Weil BR, Meldrum DR. Pretreatment with intracoronary mimosine improves postischemic myocardial functional recovery. Surgery. 2011 Aug;150(2):191-6.

Manukyan MC, Alvernaz CH, Poynter JA, Wang Y, Brewster BD, Weil BR, Abarbanell AM, Herrmann JL, Crowe BJ, Keck AC, Meldrum DR. Interleukin-10 protects the ischemic heart from reperfusion injury via the STAT3 pathway. Surgery. 2011 Aug;150(2):231-9.

Manukyan MC, Weil BR, Wang Y, Abarbanell AM, Herrmann JL, Poynter JA, Brewster BD, Meldrum DR. Female stem cells are superior to males in preserving myocardial function following endotoxemia. Am J Physiol Regul Integr Comp Physiol. 2011 Jun;300(6):R1506-14.

Weil BR, Manukyan MC, Herrmann JL, Abarbanell AM, Poynter JA, Wang Y, Meldrum DR. The immunomodulatory properties of mesenchymal stem cells: implications for surgical disease. J Surg Res. 2011 May 1;167(1):78-86.

Herrmann JL, Weil BR, Abarbanell AM, Wang Y, Poynter JA, Manukyan MC, Meldrum DR. IL-6 and TGF-alphs costimulate mesenchymal stem cell vascular endothelial growth factor production by ERK-, JNK-, and PI3K-mediated mechanisms. Shock. 2011 May;35(5):512-6

Herrmann JL, Abarbanell AM, Weil BR, Manukyan MC, Poynter JA, Brewster BJ, Wang Y, Meldrum DR. Optimizing stem cell function for the treatment of ischemic heart disease. J Surg Res. 2011 Mar;166(1):138-45.

Abarbanell AM, Hartley JA, Herrmann JL, Weil BR, Wang Y, Manukyan MC, Poynter JA, Meldrum DR. Exogenous high-mobility group box 1 improves myocardial recovery after acute global ischemia/reperfusion injury. Surgery. 2011 Mar;149(3):329-35.

Abarbanell AM*, Wang Y*, Herrmann JL, Weil BR, Manukyan MC, Poynter JA, Meldrum DR. TLR4 inhibits mesenchymal stem cell (MSC) STAT3 activation and thereby exerts deleterious effects on MSC-mediated cardioprotection. PLoS One. 2010 Dec 3;5(12):e14206.

Dr. Abarbanell on PubMed